The Cochrane Collaboration as key player in the struggle for better and more relevant patients- and system-oriented research

Liberati, Alessandro

doi:10.1017/s2045796011000424

Cited by 5 publications

(4 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They also need to understand patient values, preferences and their desired involvement and information, by adopting a shared approach towards therapeutic decisions. This implies to have more effective and transparent ways to produce relevant research results (Liberati, 2011) and to disseminate them in an appropriate manner (Internet may help or be harmful and its influence has to be considered more during clinical consultations). Moreover, research results and patient knowledge have to be reconciled and should emerge during the consultation in a way that is not stigmatising for the patients or their families, who also have the right and the need to be informed, educated and, whenever possible, involved.…”

Section: Resultsmentioning

confidence: 99%

People-centred care: new research needs and methods in doctor–patient communication. Challenges in mental health

Piccolo¹,

Goss²

2012

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

Communication in psychiatry is nowadays called to create bridges between different levels of observation (biological, functional and relational levels) and therapeutic intervention (social and educational) with important implications for therapeutic practice and communication research in the mental health context. New research challenges and windows of opportunity for therapeutic practice will be addressed in this contribution, as they relate to the three main tasks that psychiatrists have to meet when talking with their patients: understanding patient's problems and concerns; establishing the therapeutic alliance by acknowledging and responding to patient's emotion; informing and involving patients and their families, when appropriate. Therapeutic decisions need the elaboration of valid strategies of shared decisionmaking, which still have to be implemented and adapted to psychiatric context. Moreover, in the research field, emerging biomarker research may contribute to better explain what makes the difference in an empathic relationship either in terms of psycho-physiological reactions and in brain changes. Finally, the influence of new technologies and of Internet has to be more and more considered during clinical consultations.

show abstract

Section: Resultsmentioning

confidence: 99%

People-centred care: new research needs and methods in doctor–patient communication. Challenges in mental health

Piccolo¹,

Goss²

2012

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

show abstract

“…In 2002, in response to growing concerns about the methodology followed to update the list, an approach based on a more systematic assessment of the evidence base was adopted, which included careful appraisal of efficacy, safety, cost-effectiveness and public-health relevance. Links with the Cochrane Collaboration were established in order to make better evidence-based decisions (Laing et al 2003; Liberati, 2011).…”

mentioning

confidence: 99%

What is the WHO essential medicines list?

Purgato

Barbui

2012

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

This Section of Epidemiology and Psychiatric Sciences regularly appears in each issue of the Journal to cover methodological aspects related to the design, conduct, reporting and interpretation of clinical and epidemiological studies. The aim of these Editorials is to help developing a more critical attitude towards research findings published in international literature, promoting original research projects with higher methodological standards, and implementing the most relevant results of research in every-day clinical practice. This article briefly presents the main characteristics of the World Health Organization (WHO) essential medicines list (EML), a register of minimum medicine needs for every health-care system. The idea behind the list is that the use of a limited number of well-known and cost-effective medicines may lead to improved long-term medicine supply, lower costs and better health care provision. The World Health Organization (WHO), established in 1948 after the Second World War, is a specialized agency of the United Nations serving as the directing and coordinating authority for international health matters and public health (World Health Organization, 2009). One of WHO's constitutional functions is to offer objective and reliable information and advice in the field of human health. The organization seeks through its publications to support national health strategies addressing the most pressing public health concerns of populations around the world. To respond to the needs of Member States at all levels of development, WHO publishes practical manuals, handbooks and training material, guidelines, analyses of health policies and lists of medicines to treat priority health care conditions (World Health Organization, 2009).The WHO essential medicines list (EML) is a register of minimum medicine needs for every health-care system (Bloom, 2011). The basic concept is that high priority drugs should be available as part of a functioning health system at all times for all people, guiding physicians to evidence-based and rational prescribing. The idea behind the list is that the use of a limited number of well-known and cost-effective medicines leads to improved long-term medicine supply, lower costs, better health care and more equitable and sustainable access to products (Hutchings et al. 2010).First published in 1977, the EML is revised every 2 years by a committee of experts from around the world in fields such as medicine, pharmacology, policy, regulation and health organizations (Hutchings et al. 2010). The expert committee updates the model list to reflect changes in global health concerns, pharmaceutical developments and patterns of drug resistance. The current version is the 17th WHO EML (updated in March 2011). The list is meant not to replace individual, national EML, but rather to be used as a guide to inform purchasing decisions in the context of national health agendas (Kishore & Herbstman, 2009

show abstract

“…In this issue of Epidemiology and Psychiatric Sciences three Editorials discuss the extent to which Cochrane reviews have been able to help doctors and policymakers make decisions, and whether the goal of implementing an evidence-based practice is getting closer (Adams, 2011; Davoli & Amato, 2011; Liberati, 2011). The authors of the three Editorials seem to agree that the Cochrane Collaboration represents a successful example of international effort aimed at providing an answer to the growing demand for valid and reliable information on the effects of health care interventions.…”

mentioning

confidence: 99%

“…In questo numero di Epidemiology and Psychiatric Sciences tre Editoriali affrontano il tema dell'impatto delle revisioni Cochrane sulla pratica clinica e sulle politiche sanitarie, con l'intento di comprendere se l'obiettivo di realizzare una pratica clinica realmente basata sulle prove di efficacia si stia concretizzando (Adams, 2011; Davoli & Amato, 2011; Liberati, 2011). Gli autori dei tre Editoriali concordano nel ritenere che la Cochrane Collaboration rappresenti un esempio positivo di come sia possibile attivare uno sforzo internazionale e spontaneo per cercare di dare risposta alla domanda crescente di informazioni valide e affidabili sugli effetti degli interventi in ambito sanitario.…”

unclassified

Cochrane reviews impact on mental health policy and practice

Barbui

Tansella²

2011

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

The Cochrane Collaboration as key player in the struggle for better and more relevant patients- and system-oriented research

Cited by 5 publications

References 24 publications

People-centred care: new research needs and methods in doctor–patient communication. Challenges in mental health

People-centred care: new research needs and methods in doctor–patient communication. Challenges in mental health

What is the WHO essential medicines list?

Cochrane reviews impact on mental health policy and practice

Contact Info

Product

Resources

About